Quoin Pharmaceuticals Ltd. SEC filings QNRX
Quoin Pharmaceuticals Ltd. has 581 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 4, 2026 | Nov 4, 2026 |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| S-3 | Shelf registration | Oct 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| DEF 14A | Proxy statement | Oct 2, 2026 | Nov 12, 2026 |
| EFFECT | Filing | Sep 25, 2026 | — |
| 424B3 | Prospectus | Sep 25, 2026 | — |
| PRE 14A | Preliminary proxy statement | Sep 22, 2026 | Nov 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2026 | Sep 22, 2026 |
| S-3 | Shelf registration | Sep 18, 2026 | — |
| D | Filing | Sep 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Aug 20, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Jul 16, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Jul 16, 2026 | Aug 20, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 6, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 20, 2026 | Jan 20, 2026 |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| EFFECT | Filing | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2025 | Nov 11, 2025 |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| D | Filing | Oct 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 15, 2025 | Oct 10, 2025 |
| S-8 | Employee stock plan registration | Aug 27, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2025 | Aug 21, 2025 |
| S-8 | Employee stock plan registration | Aug 25, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
|
Aug 21, 2025 | Aug 15, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| ARS | Annual report to shareholders | Jul 17, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 17, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2025 | Jul 3, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Other events
|
May 21, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 30, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Apr 4, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Apr 4, 2025 | Apr 4, 2025 |
| EFFECT | Filing | Apr 3, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 2, 2025 | Apr 2, 2025 |
| POS AM | Filing | Mar 28, 2025 | — |
| 8-K |
Current report
Auditor change
|
Mar 20, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Other events
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Other events
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 16, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 6, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 26, 2024 | Dec 20, 2024 |
| 424B4 | Prospectus | Dec 23, 2024 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| S-1/A | Amended registration statement | Dec 18, 2024 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| S-1 | Registration statement | Dec 11, 2024 | — |
| 424B3 | Prospectus | Dec 11, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Other events
|
Dec 10, 2024 | Dec 5, 2024 |
| 424B3 | Prospectus | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 31, 2024 | Oct 29, 2024 |
| DEF 14A | Proxy statement | Oct 24, 2024 | Dec 5, 2024 |
| ARS | Annual report to shareholders | Oct 24, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 11, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 8, 2024 |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 424B3 | Prospectus | May 10, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 424B3 | Prospectus | May 8, 2024 | — |
| 8-K |
Current report
Listing notice
|
May 3, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 9, 2024 | Apr 5, 2024 |
| EFFECT | Filing | Apr 3, 2024 | — |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| POS AM | Filing | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 424B3 | Prospectus | Mar 8, 2024 | — |
| 424B3 | Prospectus | Mar 8, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 8, 2024 | Mar 4, 2024 |
| 424B4 | Prospectus | Mar 6, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2024 | Feb 29, 2024 |
| 424B3 | Prospectus | Mar 4, 2024 | — |
| DEF 14A | Proxy statement | Feb 27, 2024 | Mar 29, 2024 |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| S-1/A | Amended registration statement | Feb 13, 2024 | — |
| PRE 14A | Preliminary proxy statement | Feb 13, 2024 | Mar 29, 2024 |
| S-1 | Registration statement | Feb 12, 2024 | — |
| 424B3 | Prospectus | Jan 31, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 30, 2024 | Jan 25, 2024 |
| 424B3 | Prospectus | Dec 18, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 13, 2023 |
| 424B3 | Prospectus | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 8, 2023 |
| 424B3 | Prospectus | Nov 7, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Shareholder vote results
|
Nov 6, 2023 | Nov 5, 2023 |
| 424B3 | Prospectus | Nov 1, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Nov 1, 2023 | Oct 26, 2023 |
| DEFA14A | Additional proxy material | Oct 19, 2023 | — |
| 424B3 | Prospectus | Sep 14, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 13, 2023 | Sep 6, 2023 |
| ARS | Annual report to shareholders | Sep 12, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Sep 12, 2023 | Oct 19, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2023 | Sep 1, 2023 |
| 424B3 | Prospectus | Aug 3, 2023 | — |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 2, 2023 | Aug 2, 2023 |
| 424B3 | Prospectus | Jul 18, 2023 | — |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Jul 14, 2023 | Jun 22, 2023 |
| 424B3 | Prospectus | Jun 28, 2023 | — |
| 8-K |
Current report
Change to shareholder rights
|
Jun 28, 2023 | Jun 22, 2023 |
| 424B3 | Prospectus | May 12, 2023 | — |
| 8-K |
Current report
Other events
|
May 12, 2023 | May 9, 2023 |
| 424B3 | Prospectus | May 9, 2023 | — |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 424B3 | Prospectus | Apr 7, 2023 | — |
| 8-K |
Current report
Listing notice
|
Apr 7, 2023 | Apr 5, 2023 |
| 424B3 | Prospectus | Mar 22, 2023 | — |
| EFFECT | Filing | Mar 17, 2023 | — |
| POS AM | Filing | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 8, 2023 |
| 424B3 | Prospectus | Feb 28, 2023 | — |
| 424B3 | Prospectus | Feb 28, 2023 | — |
| 424B3 | Prospectus | Feb 28, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 28, 2023 | Feb 22, 2023 |
| 424B4 | Prospectus | Feb 23, 2023 | — |
| EFFECT | Filing | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| S-1/A | Amended registration statement | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2023 | — |
| S-1 | Registration statement | Feb 3, 2023 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Sep 30, 2022 |
| 424B3 | Prospectus | Nov 7, 2022 | — |
| 424B3 | Prospectus | Nov 7, 2022 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 424B3 | Prospectus | Oct 28, 2022 | — |
| 424B3 | Prospectus | Oct 28, 2022 | — |
| 6-K | Current report (foreign issuer) | Oct 28, 2022 | Oct 27, 2022 |
| 424B3 | Prospectus | Sep 21, 2022 | — |
| 424B3 | Prospectus | Sep 21, 2022 | — |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| D | Filing | Aug 31, 2022 | — |
| 424B3 | Prospectus | Aug 18, 2022 | — |
| 424B3 | Prospectus | Aug 18, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 18, 2022 | Jun 30, 2022 |
| POS EX | Filing | Aug 11, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2022 | Aug 10, 2022 |
| 424B4 | Prospectus | Aug 9, 2022 | — |
| EFFECT | Filing | Aug 5, 2022 | — |
| F-1MEF | Filing | Aug 5, 2022 | — |
| CORRESP | Letter to the SEC | Aug 4, 2022 | — |
| CORRESP | Letter to the SEC | Aug 4, 2022 | — |
| F-1/A | Filing | Aug 4, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Aug 3, 2022 | — |
| 424B3 | Prospectus | Jul 15, 2022 | — |
| 6-K | Current report (foreign issuer) | Jul 15, 2022 | Jul 15, 2022 |
| RW | Filing | Jun 30, 2022 | — |
| 424B3 | Prospectus | Jun 17, 2022 | — |
| 6-K | Current report (foreign issuer) | Jun 17, 2022 | Jun 16, 2022 |
| F-3 | Shelf registration (foreign issuer) | Jun 14, 2022 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QNRX (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- Ashburn, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671502
- Former names
- Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.